The days ahead pack several binary or near-binary catalysts for U.S. biotech and biopharma companies—decisions that could ...
Actress Gulfam Khan Hussain has voiced her concerns over the changing landscape of Indian television. The veteran actress ...
Replimune Group Inc. Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was ...
Replimune Group faces a pivotal FDA decision for RP1 in advanced melanoma, with a Sell rating reflecting approval odds and the current price. Learn more about REPL stock here.
The smell of fresh-baked Greek pastries is filling the air in Wheeling this week as Grecian Fest returns for its 25th ...
Complete Replimune Group Inc. stock information by Barron's. View real-time REPL stock price and news, along with ...
Rachel Reeves said growth was her “number one mission”. She has failed. New GDP figures show that the economy continues to flatline, cementing her legacy as one of the most ineffectual chancellors the ...
Detailed price information for Replimune Group Inc (REPL-Q) from The Globe and Mail including charting and trades.
Replimune Group, Inc. (Nasdaq: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced financial results for the fiscal fourth ...
Detailed price information for Replimune Group Inc (REPL-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results